British American Tobacco plc Heading For 9% Growth

Forecasts indicate a return to earnings growth for British American Tobacco plc (LON: BATS)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Earnings growth at British American Tobacco (LSE: BATS) (NYSE: BTI.US) has been sliding over the past five years. Back in 2009, the purveyor of the deadly weed enjoyed a 19% rise in earnings per share (EPS), but since then the annual rise has slowed as far as last year’s 5% — and there’s a small fall of 1% forecast for the year to December 2014.

british american tobacco / imperial tobaccoDividend growth has been slowing too, from the days of 14% growth in 2010 to 5.6% in 2013, although that is not expected to turn negative along with earnings. In fact, there’s still a dividend boost of 3.8% forecast for this year, to take the payout to 147p and provide a yield of 4.3% on a 3,464p share price.

2015 reversal

And expectations for 2015 are currently indicating a reversal of recent fortunes — we have a 9% EPS rise penciled in, together with a 7% hike in the dividend to take the yield up to 4.6%.

These predictions are way down on the analysts’ positions 12 months ago, mind — back then the consensus suggested EPS of 251p for 2014 with a dividend of 164p, and it’s a big drop to the latest 215p and 147p respectively.

Share price picking up

The share price has been falling for much of the past year too, and early in 2014 it had dropped around 20% — but we’ve since seen a recovery to take us back to a modest 5% slip over 12 months.

The problems for the tobacco business are well known — people are simply smoking less, and stick volumes at British American and rival Imperial Tobacco have been steadily falling year-on-year. But a switch in focus towards premium-priced brands has helped keep earnings rising, albeit at a slower pace.

Surprisingly popular

That, the healthy nature of the dividends (if not the companies’ products), coupled with the largely defensive nature of the business as an investment, has helped keep the punters bullish on British American shares.

In fact, out of a sample of 23 analysts, 13 rate the shares a Buy or a Strong Buy, with only two thinking we should sell the shares — the remaining eight are sticking with a Hold stance.

Not for the long term

Are the commentators right and should we buy British American Tobacco? Well, the City does tend to have a short-term outlook, and with a forward P/E of 16 for this year dropping to 14.5 for 2015, the shares are not overvalued in the short term.

But if you have a 10 or 20-year horizon, there are surely better places for your investment cash than a declining industry.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan does not own any shares in British American Tobacco.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in May [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »